##common.pageHeaderLogo.altText##

Vol. 5 No. 02 (2025)

Thalassemia and Hemoglobinopathies In Pediatric Populations: Prevalence, Diagnostic Insights, And Regional Patterns

Clinical Medicine And Health Research Journal, Vol. 5 No. 02 (2025), 14 April 2025 , Page 1241-1247
https://doi.org/10.18535/cmhrj.v5i02.460

Abstract

Thalassemia and related hemoglobinopathies are inherited disorders affecting hemoglobin production, leading to anemia and other health complications. The average prevalence of β thalassemia trait in India is 3-4% which is 42 million carriers of 121 billion people. This study examines the distribution of hemoglobinopathies among 19,935 pediatric cases across various regions in India, highlighting the importance of early screening and targeted interventions. High-performance liquid chromatography (HPLC) was utilized for accurate detection of hemoglobin variants, with findings showing significant regional and demographic differences in disease prevalence.Maximum positivity was seen in children between 4-9 yrs (69.78%), the percentage of positivity seen among infants <1 yr was also significant (28.50%). These prevalence trends seen in Indian paediatric population suggest that prenatal screening should be mandated for the high-risk groups.

Keywords:
  • Hemoglobinopathies
  • Thalassemia
  • Anemia
  • HPLC

How to Cite

Dr Smita Hiras Sudke, Dr Moindrila Halder, Jatale, R., Dr Shibani Ramchandran, & Dr Anita Suryanarayan. (2025). Thalassemia and Hemoglobinopathies In Pediatric Populations: Prevalence, Diagnostic Insights, And Regional Patterns. Clinical Medicine And Health Research Journal, 5(02), 1241–1247. https://doi.org/10.18535/cmhrj.v5i02.460

Download Citation

References

  • Balgir RS. Genetic epidemiology of three predominant abnormal hemoglobins in India. J Assoc Physicians India. 1996;44:25–8. [PubMed] [Google Scholar]
  • Borgna-Pignatti C, Galanello R. Thalassemias and related disorders: Quantitative disorders of hemoglobin synthesis. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Parakevas F, Glader B, editors. Wintrobes Clinical Hematology. Philadelphia: Lippincott Willams and Wilkins; 2004. pp. 1319–65. [Google Scholar]
  • Chatterjea JB. Some aspects of HbE and its genetic interaction with thalassemia. Indian J Med Res. 1965;53:377–83. [PubMed] [Google Scholar]
  • Gupta SC, Mehrotra TN, Mehrotra VG. Haemoglobin-E-thalassaemia in Uttar Pradesh. Indian J Med Res. 1970;58:857–62. [PubMed] [Google Scholar]
  • Shukla RM, Solanki BR. Sickle-cell trait in Central India. Lancet. 1985;1:297-8 [PubMed] [Google Scholar]
  • Kamle M, Chaturvedi P. Epidemiology of sickle cell disease in a rural hospital in central India. Indian Pediatr. 2000;37:391–6. [PubMed] [Google Scholar]
  • ao S, Kar R, Gupta SK, Chopra A, Saxena R. Spectrum of hemoglobinopathies diagnosed by cation exchange-HPLC and modulating effects of nutritional deficiency anaemias from north India. Indian J Med Res. 2010;132:513–9. [PMC free article] [PubMed] [Google Scholar]
  • Bravo-Urquuiola M, Arends A, Montilla S, Velasquez D, Garcia G, Alvarez M, et al. Advantages in the use of high performance chromatography technique for screening hemoglobinopathies in Venezuela. Invest Clin. 2004;45:309–15. [PubMed] [Google Scholar]
  • Surabhi S Yadav , Pooja Panchal , Kavitha C Menon: Prevalence and Management of β-Thalassemia in India. Hemoglobin.2022 Jan;46(1): 27-32.doi:10.1080/03630269.2021.2001346. Epub 2022 Feb 7.
  • Pratik Singh, Samir Shaikh, Sagar Parmar and Reeshu Gupta. HEMOGLOBIN https://doi.org/10.1080/03630269.2023.2269837 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537975/#
  • J Community Genet.2013 Jan; 4(1): 33–42. Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study
  • D. Mohanty, R. B. Colah, A. C. Gorakshakar, R. Z. Patel, D. C. Master, J. Mahanta, S. K. Sharma, U. Chaudhari, M. Ghosh, S. Das, R. P. Britt, S. Singh, C. Ross, L. Jagannathan, R. Kaul, D. K. Shukla, and V. Muthuswamy
  • Purohit, A., Singh, K., Kalla, A. R., Bohra, M., Kumar, M., & Saini, S. (2021). Evaluation of β-Thalassaemia Cases for Common Mutations in Western Rajasthan. Indian Journal of Hematology and Blood Transfusion, 37(4), 684–688. https://doi.org/10.1007/s12288-021-01414-z
  • Chakravorty, S., & Dick, M. C. (2019). Antenatal screening for haemoglobinopathies: current status, barriers and ethics. British Journal of Haematology. https://doi.org/10.1111/bjh.16188
  • Mensah, C., & Sheth, S. (2021). Optimal strategies for carrier screening and prenatal diagnosis of α- and β-thalassemia. Hematology: American Society of Hematology Education Program, 2021(1), 607–613. https://doi.org/10.1182/hematology.2021000296
  • Saraf, S. L., Molokie, R. E., Nouraie, M., Sable, C. A., Luchtman-Jones, L., Ensing, G. J., Campbell, A. D., Rana, S. R., Niu, X. M., Machado, R. F., Gladwin, M. T., & Gordeuk, V. R. (2013). Differences in the clinical and genotypic presentation of sickle cell disease around the world. Paediatric Respiratory Reviews, 15(1), 4–12. https://doi.org/10.1016/j.prrv.2013.11.003
  • Sur, D., & Chakravorty, R. (2016). Prevalence of hemoglobinopathies and thalassemia carriers in women of reproductive age group especially the prospective mothers: a single center study at West Bengal. Journal of Hematology, 5(3), 99–102. https://doi.org/10.14740/jh297w
    • Article Viewed: 0 Total Download

    ##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##

    Cover Image

    Information